PE Ratio

Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.

P/E RATIO
EPS

The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.

EPS
PRICE/BOOK

Price-to-book ratio is used to compared the company's current market price with its book value.

PRICE/BOOK
Deliverable

These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.

DELIVERABLES
DIV YIELD.(%)

Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.

DIV YIELD.(%)

Company Details

Check out the key parameters of the company to understand the financial health and stock performance

Key Level

Resistance 1
-
Resistance 2
-
Support 1
-
Support 2
-

Moving Average

20 Days
-
50 Days
-
100 Days
-
200 Days
-
Growth in 3 years

Sales


Sales Industry Avg


PAT


PAT Industry Avg


Growth in 3 years

Total Asset Growth
26.45%

Total Liabilities growth
9.50%

Reserves Change
-6.41%



Relative to Sensex rtn in 3 year


Relative to Nifty rtn in 3 year


Relative to top 3 MF rtn in 3 year


2016 2014 2014
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14
Sales 59.91 59.91 59.91
Gross Profit 60.14 60.14 60.14
Operating Profit 6.14 6.14 6.14

Peer Companies

A quick glance on how stocks from the same sector have performed along with some key parameters

View More

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

 

If I had made
investment of  
in
Months Ago
My investment would be worth with a of %

Our Research Reports

Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.

View More

Corporate Action

Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.

FnO

A snapshot on how the stock has performed in the derivatives segment on a real-time basis.

View More

MF Holdings

Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.

Scheme Name AUM (%) CMV ( in Cr.) Holding Date
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
Aditya Birla Nuvo Ltd 35.67 35.67 35.67
View More

News

Stay tuned to the latest developments and happenings in the company.

Zydus Lifesciences receives USFDA approval for Isosorbide Mononitrate ER Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture and market Isosorbide Mon....

16 Feb 2024 14:31

Board of Zydus Lifesciences approves buyback of Rs 600 cr

The Board of Zydus Lifesciences at its meeting held on 09 February 2024 has approved proposal to buyback 59,70,149 equity shares of the company (5.28....

09 Feb 2024 17:50

Zydus Lifesciences consolidated net profit rises 26.76% in the December 2023 quarter

Net profit of Zydus Lifesciences rose 26.76% to Rs 789.60 crore in the quarter ended December 2023 as against Rs 622.90 crore during the previous quar....

09 Feb 2024 14:29

Board of Zydus Lifesciences to consider buyback of shares

The Board of Zydus Lifesciences will meet on 09 February 2024 to consider a proposal for buyback of shares. Powered by Capital Market - ....

05 Feb 2024 18:54

Zydus Lifesciences consolidated net profit rises 53.24% in the September 2023 quarter

Net profit of Zydus Lifesciences rose 53.24% to Rs 800.70 crore in the quarter ended September 2023 as against Rs 522.50 crore during the previous qua....

07 Nov 2023 12:50

Zydus Lifesciences consolidated net profit rises 109.70% in the June 2023 quarter

Net profit of Zydus Lifesciences rose 109.70% to Rs 1086.90 crore in the quarter ended June 2023 as against Rs 518.30 crore during the previous quarte....

11 Aug 2023 17:49

View More
Subscribe for our
newsletter
Open Account Now